Surgery Partners (NASDAQ:SGRY) Exceeds Q4 Expectations
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 17.5% year on year to $864.4 million. The company expects the full year’s revenue to be around $3.38 billion, close to analysts’ estimates. Its non-GAAP profit of $0.44 per share was 16.7% above analysts’ consensus estimates.